If a clinically meaningful increase in heart rate is identified during retatrutide treatment, several management strategies may be considered, depending on the severity of the elevation and the presence of associated symptoms
Murillo MI, Gaiddon C, Le Lagadec R
one study had several flaws (unmatched controls, unclear cancer stage classification), while the best-designed one had negative results [68, 69, 64, 66, 67]
4,18 Data suggest that dulaglutide and liraglutide may be associated with higher rates of nausea, vomiting, and constipation compared with semaglutide, whereas pharmacovigilance analyses indicate that semaglutide carries the greatest signal strength for these AEs
Partner with your team to custom-tailor a procedure plan to meet your body goals